SG11201706809WA - Non-human animal exhibiting diminished upper and lower motor neuron function and sensory perception - Google Patents

Non-human animal exhibiting diminished upper and lower motor neuron function and sensory perception

Info

Publication number
SG11201706809WA
SG11201706809WA SG11201706809WA SG11201706809WA SG11201706809WA SG 11201706809W A SG11201706809W A SG 11201706809WA SG 11201706809W A SG11201706809W A SG 11201706809WA SG 11201706809W A SG11201706809W A SG 11201706809WA SG 11201706809W A SG11201706809W A SG 11201706809WA
Authority
SG
Singapore
Prior art keywords
human animal
motor neuron
lower motor
sensory perception
neuron function
Prior art date
Application number
SG11201706809WA
Inventor
Burcin Ikiz
Michael LaCroix-Fralish
Susan D Croll
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of SG11201706809WA publication Critical patent/SG11201706809WA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278Knock-in vertebrates, e.g. humanised vertebrates
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276Knock-out vertebrates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058Neurological cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082Supracellular entities, e.g. tissue, organisms
    • G01N33/5088Supracellular entities, e.g. tissue, organisms of vertebrates
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • A01K2217/075Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • A01K2217/075Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A01K2217/077Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out heterozygous knock out animals displaying phenotype
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/105Murine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/03Animal model, e.g. for test or diseases
    • A01K2267/0306Animal model for genetic diseases
    • A01K2267/0318Animal model for neurodegenerative disease, e.g. non- Alzheimer's
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/03Animal model, e.g. for test or diseases
    • A01K2267/0393Animal model comprising a reporter system for screening tests
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/61Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Environmental Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11201706809WA 2015-03-16 2016-03-16 Non-human animal exhibiting diminished upper and lower motor neuron function and sensory perception SG11201706809WA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562133909P 2015-03-16 2015-03-16
US201562250229P 2015-11-03 2015-11-03
PCT/US2016/022685 WO2016149398A1 (en) 2015-03-16 2016-03-16 Non-human animal exhibiting diminished upper and lower motor neuron function and sensory perception

Publications (1)

Publication Number Publication Date
SG11201706809WA true SG11201706809WA (en) 2017-09-28

Family

ID=55646893

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201912899QA SG10201912899QA (en) 2015-03-16 2016-03-16 Non-human animal exhibiting diminished upper and lower motor neuron function and sensory perception
SG11201706809WA SG11201706809WA (en) 2015-03-16 2016-03-16 Non-human animal exhibiting diminished upper and lower motor neuron function and sensory perception

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10201912899QA SG10201912899QA (en) 2015-03-16 2016-03-16 Non-human animal exhibiting diminished upper and lower motor neuron function and sensory perception

Country Status (15)

Country Link
US (3) US10285387B2 (en)
EP (2) EP3270688B1 (en)
JP (4) JP6600694B2 (en)
KR (2) KR102616160B1 (en)
CN (1) CN107690279B (en)
AU (2) AU2016233250C1 (en)
BR (1) BR112017019620A2 (en)
CA (1) CA2978096C (en)
ES (2) ES2830173T3 (en)
HK (1) HK1249360A1 (en)
IL (2) IL274285B (en)
MX (2) MX2017011918A (en)
RU (1) RU2744831C2 (en)
SG (2) SG10201912899QA (en)
WO (1) WO2016149398A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102138723B1 (en) * 2013-08-07 2020-07-29 리제너론 파마슈티칼스 인코포레이티드 Lincrna-deficient non-human animals
WO2018064600A1 (en) * 2016-09-30 2018-04-05 Regeneron Pharmaceuticals, Inc. Non-human animals having a hexanucleotide repeat expansion in a c9orf72 locus
CN111849899B (en) * 2017-07-28 2022-06-14 杨涛 Induction medium for directionally inducing differentiation of hipscs into neural cell system
CN107586791B (en) * 2017-10-26 2018-09-21 四川省人民医院 A kind of construction method of incoordination animal model and application

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566089B1 (en) * 1996-09-04 2003-05-20 Tularik Inc. Cell-based drug screens for regulators of gene expression
US6949358B1 (en) 1997-06-11 2005-09-27 Human Genome Sciences, Inc. Human tumor necrosis factor receptor TR9
US6358508B1 (en) 1997-06-11 2002-03-19 Human Genome Sciences, Inc. Antibodies to human tumor necrosis factor receptor TR9
WO1999005266A2 (en) 1997-07-26 1999-02-04 Wisconsin Alumni Research Foundation Trans-species nuclear transfer
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US20050144655A1 (en) 2000-10-31 2005-06-30 Economides Aris N. Methods of modifying eukaryotic cells
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7105348B2 (en) 2000-10-31 2006-09-12 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
AUPR451401A0 (en) 2001-04-20 2001-05-24 Monash University A method of nuclear transfer
US20050069540A1 (en) 2001-12-17 2005-03-31 Jinqi Liu Treating b-cell mediated diseases by modulating dr6 activity
US7612250B2 (en) 2002-07-29 2009-11-03 Trustees Of Tufts College Nuclear transfer embryo formation method
ES2667169T3 (en) 2004-10-19 2018-05-09 Regeneron Pharmaceuticals, Inc. Method to generate a homozygous non-human animal for genetic modification
CN101117633B (en) 2006-08-03 2011-07-20 上海交通大学附属儿童医院 Nucleus transplantation method
CN101616934A (en) * 2006-12-22 2009-12-30 健泰科生物技术公司 Suppress DR6 antibody and the purposes in treatment neuroscience illness thereof of DR6 in conjunction with APP
US20100203044A1 (en) 2006-12-22 2010-08-12 Anatoly Nikolaev Dr6 antagonists and uses thereof in treating neurological disorders
TWI476280B (en) 2008-03-07 2015-03-11 Regeneron Pharma Es-cell-derived mice from diploid host embryo injection
EP2294413A4 (en) * 2008-06-12 2012-04-25 Genentech Inc Method for screening for compounds that inhibit neurodegeneration
WO2010062904A2 (en) 2008-11-25 2010-06-03 Biogen Idec Ma Inc. Use of dr6 and p75 antagonists to promote survival of cells of the nervous system
TW201034684A (en) * 2009-02-18 2010-10-01 Genentech Inc Method for inhibiting neurodegeneration
RU2425880C2 (en) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Method of producing transgene mice
WO2011020005A1 (en) 2009-08-14 2011-02-17 Regeneron Pharmaceuticals, Inc. miRNA-REGULATED DIFFERENTIATION-DEPENDENT SELF-DELETING CASSETTE
WO2011059799A1 (en) 2009-10-29 2011-05-19 Regeneron Pharmaceuticals, Inc. Multifunctional alleles
PL2847335T3 (en) 2012-04-25 2019-01-31 Regeneron Pharmaceuticals, Inc. Nuclease-mediated targeting with large targeting vectors
EP2958990B1 (en) 2013-02-20 2019-10-16 Regeneron Pharmaceuticals, Inc. Genetic modification of rats
HUE040575T2 (en) 2013-04-16 2019-03-28 Regeneron Pharma Targeted modification of rat genome
MX2016007654A (en) 2013-12-11 2017-08-15 Regeneron Pharma Methods and compositions for the targeted modification of a genome.

Also Published As

Publication number Publication date
US20190261610A1 (en) 2019-08-29
JP2022048157A (en) 2022-03-25
ES2830173T3 (en) 2021-06-03
IL274285A (en) 2020-06-30
US20160270377A1 (en) 2016-09-22
US20210392865A1 (en) 2021-12-23
HK1249360A1 (en) 2018-11-02
CA2978096A1 (en) 2016-09-22
KR102424119B1 (en) 2022-07-25
US10285387B2 (en) 2019-05-14
JP2020198892A (en) 2020-12-17
EP3685662A1 (en) 2020-07-29
KR20170127459A (en) 2017-11-21
IL254333A0 (en) 2017-11-30
IL254333B (en) 2020-05-31
JP2020005660A (en) 2020-01-16
EP3685662B9 (en) 2023-10-04
CN107690279A (en) 2018-02-13
AU2022200784A1 (en) 2022-02-24
BR112017019620A2 (en) 2018-05-15
AU2016233250A1 (en) 2017-09-14
EP3270688B1 (en) 2020-08-12
ES2955841T3 (en) 2023-12-07
AU2016233250C1 (en) 2022-08-18
KR102616160B1 (en) 2023-12-22
WO2016149398A1 (en) 2016-09-22
JP7193509B2 (en) 2022-12-20
MX2021002852A (en) 2021-05-28
CA2978096C (en) 2022-06-28
AU2016233250B2 (en) 2022-03-03
EP3685662B1 (en) 2023-06-07
IL274285B (en) 2022-07-01
KR20220108828A (en) 2022-08-03
JP6600694B2 (en) 2019-10-30
CN107690279B (en) 2021-07-02
RU2017135557A3 (en) 2019-07-29
RU2744831C2 (en) 2021-03-16
EP3270688A1 (en) 2018-01-24
RU2017135557A (en) 2019-04-17
EP3685662C0 (en) 2023-06-07
SG10201912899QA (en) 2020-02-27
NZ734906A (en) 2022-02-25
AU2022200784B2 (en) 2024-02-15
JP2018512842A (en) 2018-05-24
MX2017011918A (en) 2018-05-22

Similar Documents

Publication Publication Date Title
IL288264A (en) Genetically modified non-human animals expressing human epo
IL258006B (en) Automatically classifying animal behavior
PL3314343T3 (en) Personal sensory drones
GB201718756D0 (en) Neural interface
ZA201607866B (en) Solid-stabilized emulsion
IL274285A (en) Non-human animal exhibiting diminished upper and lower motor neuron function and sensory perception
HUE038380T2 (en) Edible animal chew
GB201608958D0 (en) Implantable neural interface
EP3362116C0 (en) Fat filtration device
GB201717748D0 (en) Autonomous vehicle ingress and egress
GB201521318D0 (en) Motorised karts
EP3589356C0 (en) Transcranial stimulation with real-time monitoring
GB2551430B (en) Animal monitoring
HK1198340A1 (en) It may be integrally detachable windows fence
GB2550295B (en) An improved fencing element
HK1221702A1 (en) An elevator car arrangement and a connection element
TWM475961U (en) Sensory integration stimulation device
GB201400064D0 (en) An animal alimentation device
GB201609318D0 (en) Livestock monitoring
IL245952A0 (en) Activity device
GB201510157D0 (en) Improved animal model
GB201601653D0 (en) An animal lead
GB201510241D0 (en) Animal model
GB201501765D0 (en) Sensory assessment device
HK1194600A2 (en) Pets jacuzzi